Intramuscular electrical stimulus potentiates motor cortex modulation effects on pain and descending inhibitory systems in knee osteoarthritis: a randomized, factorial, sham-controlled study.

CPM conditioned pain modulation electroacupuncture osteoarthritis pain pressure threshold tDCS transcranial direct current stimulation

Journal

Journal of pain research
ISSN: 1178-7090
Titre abrégé: J Pain Res
Pays: New Zealand
ID NLM: 101540514

Informations de publication

Date de publication:
2019
Historique:
entrez: 19 1 2019
pubmed: 19 1 2019
medline: 19 1 2019
Statut: epublish

Résumé

Neuroplastic changes in nociceptive pathways contribute to severity of symptoms in knee osteoarthritis (KOA). A new look at neuroplastic changes management includes modulation of the primary motor cortex by transcranial direct current stimulation (tDCS). We investigated whether tDCS combined with intramuscular electrical stimulation (EIMS) would be more efficacious than a sham (s) intervention (s-tDCS/s-EIMS) or a single active(a)-tDCS/s-EIMS intervention and/or s-tDCS/a-EIMS in the following domains: pain measures (visual analog scale [VAS] score and descending pain modulatory system [DPMS], and outcomes, and analgesic use, disability, and pain pressure threshold (PPT) for secondary outcomes. The trial is registered in Clinicaltrials.gov: NCT01747070. Sixty women with KOA, aged 50-75 years old, randomly received five sessions of one of the four interventions (a-tDCS/a-EIMS, s-tDCS/s-EIMS, a-tDCS/s-EIMS, and s-tDCS/a-EIMS). tDCS was applied over the primary motor cortex (M1), for 30 minutes at 2 mA and the EIMS paraspinal of L1-S2. A generalized estimating equation model revealed the main effect of the a-tDCS/a-EIMS in the VAS pain scores at end treatment compared with the other three groups ( This study provides additional evidence regarding additive clinical effects to improve pain measures and descending pain inhibitory controls when the neuromodulation of the primary motor cortex with tDCS is combined with a bottom-up modulation with EIMS in KOA. Also, it improved the ability to walk due to reduced pain and reduced analgesic use.

Sections du résumé

BACKGROUND BACKGROUND
Neuroplastic changes in nociceptive pathways contribute to severity of symptoms in knee osteoarthritis (KOA). A new look at neuroplastic changes management includes modulation of the primary motor cortex by transcranial direct current stimulation (tDCS).
OBJECTIVES OBJECTIVE
We investigated whether tDCS combined with intramuscular electrical stimulation (EIMS) would be more efficacious than a sham (s) intervention (s-tDCS/s-EIMS) or a single active(a)-tDCS/s-EIMS intervention and/or s-tDCS/a-EIMS in the following domains: pain measures (visual analog scale [VAS] score and descending pain modulatory system [DPMS], and outcomes, and analgesic use, disability, and pain pressure threshold (PPT) for secondary outcomes.
REGISTRATION BACKGROUND
The trial is registered in Clinicaltrials.gov: NCT01747070.
METHODS METHODS
Sixty women with KOA, aged 50-75 years old, randomly received five sessions of one of the four interventions (a-tDCS/a-EIMS, s-tDCS/s-EIMS, a-tDCS/s-EIMS, and s-tDCS/a-EIMS). tDCS was applied over the primary motor cortex (M1), for 30 minutes at 2 mA and the EIMS paraspinal of L1-S2.
RESULTS RESULTS
A generalized estimating equation model revealed the main effect of the a-tDCS/a-EIMS in the VAS pain scores at end treatment compared with the other three groups (
CONCLUSION CONCLUSIONS
This study provides additional evidence regarding additive clinical effects to improve pain measures and descending pain inhibitory controls when the neuromodulation of the primary motor cortex with tDCS is combined with a bottom-up modulation with EIMS in KOA. Also, it improved the ability to walk due to reduced pain and reduced analgesic use.

Identifiants

pubmed: 30655690
doi: 10.2147/JPR.S181019
pii: jpr-12-209
pmc: PMC6322702
doi:

Banques de données

ClinicalTrials.gov
['NCT01747070']

Types de publication

Journal Article

Langues

eng

Pagination

209-221

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

Pain. 1999 Nov;83(2):259-73
pubmed: 10534598
Annu Rev Neurosci. 2000;23:393-415
pubmed: 10845069
Acupunct Med. 2002 Mar;20(1):2-10
pubmed: 11926600
Nat Rev Neurosci. 2002 Dec;3(12):921-31
pubmed: 12461549
Trends Neurosci. 2003 Jan;26(1):17-22
pubmed: 12495858
Eur J Neurosci. 2005 Jul;22(2):495-504
pubmed: 16045502
Curr Rheumatol Rep. 2006 Feb;8(1):7-15
pubmed: 16515759
J Neurosci. 2007 Apr 11;27(15):4004-7
pubmed: 17428976
Neurology. 2007 Aug 28;69(9):827-34
pubmed: 17724284
Cephalalgia. 2008 Jan;28(1):1-4
pubmed: 17986275
Prog Neurobiol. 2008 Jul;85(3):297-317
pubmed: 18514997
Arthritis Rheum. 2008 Oct 15;59(10):1424-31
pubmed: 18821657
Curr Rheumatol Rep. 2008 Dec;10(6):492-9
pubmed: 19007541
Eur J Neurosci. 2009 Oct;30(7):1412-23
pubmed: 19788568
Clin J Pain. 2009 Oct;25(8):691-5
pubmed: 19920718
Support Care Cancer. 2012 Feb;20(2):319-24
pubmed: 21243377
Eur J Neurosci. 2012 Mar;35(6):805-25
pubmed: 22429242
Psychoneuroendocrinology. 2013 Jan;38(1):58-66
pubmed: 22626867
PLoS One. 2012;7(5):e36693
pubmed: 22715356
Acupunct Med. 2012 Dec;30(4):286-90
pubmed: 22871295
Pain. 2012 Dec;153(12):2359-69
pubmed: 23017297
Pain Med. 2012 Nov;13(11):1425-35
pubmed: 23036076
Clin J Pain. 2014 Mar;30(3):214-23
pubmed: 23629597
Anesthesiology. 2014 Feb;120(2):482-503
pubmed: 24322588
Rheumatol Int. 2014 Aug;34(8):1153-7
pubmed: 24399456
Acta Ortop Bras. 2013;21(5):288-94
pubmed: 24453685
Brain Stimul. 2014 May-Jun;7(3):451-9
pubmed: 24582372
Neuroscientist. 2015 Apr;21(2):185-202
pubmed: 24620008
Mol Pain. 2014 Jul 08;10:46
pubmed: 25005881
Ann Biom Biostat. 2013 Jul 5;1(1):null
pubmed: 25045756
J Altern Complement Med. 2014 Sep;20(9):698-704
pubmed: 25083759
J Pain. 2015 Feb;16(2):176-85
pubmed: 25464158
J Affect Disord. 2015 Mar 15;174:432-40
pubmed: 25553404
J Neurophysiol. 1989 Nov;62(5):1028-38
pubmed: 2585037
BMC Complement Altern Med. 2015 May 07;15:144
pubmed: 25947167
Pain Med. 2015 Sep 23;17(5):877-891
pubmed: 26398594
J Pain. 2016 Jan;17(1):14-26
pubmed: 26456677
Front Neurosci. 2016 Feb 11;10:18
pubmed: 26903788
Front Hum Neurosci. 2016 Mar 10;10:68
pubmed: 27014012
Medicine (Baltimore). 2016 Apr;95(17):e3353
pubmed: 27124022
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Clin Neurophysiol. 2017 Jan;128(1):56-92
pubmed: 27866120
Dose Response. 2017 Feb 09;15(1):1559325816685467
pubmed: 28210202
Eur J Pain. 2017 Aug;21(7):1132-1143
pubmed: 28440001
Am J Chin Med. 2017;45(5):965-985
pubmed: 28659033
Acupunct Med. 2017 Dec;35(6):392-403
pubmed: 29117967
PLoS One. 2017 Nov 30;12(11):e0187013
pubmed: 29190741
Pain Med. 2018 Aug 1;19(8):1578-1586
pubmed: 29294124
Neurol Res. 2018 Jul;40(7):555-563
pubmed: 29600889
Biometrics. 1988 Dec;44(4):1049-60
pubmed: 3233245
Ann Physiol Anthropol. 1986 Apr;5(2):89-96
pubmed: 3768108
J Rheumatol. 1996 Oct;23(10):1756-64
pubmed: 8895154

Auteurs

Maria da Graca-Tarragó (M)

Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.
Laboratory of Pain and Neuromodulation, HCPA, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.

Mateus Lech (M)

Laboratory of Pain and Neuromodulation, HCPA, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.

Letícia Dal Moro Angoleri (LDM)

Laboratory of Pain and Neuromodulation, HCPA, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.

Daniela Silva Santos (DS)

Laboratory of Pain and Neuromodulation, HCPA, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.

Alícia Deitos (A)

Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.
Laboratory of Pain and Neuromodulation, HCPA, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.

Aline Patrícia Brietzke (AP)

Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.
Laboratory of Pain and Neuromodulation, HCPA, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.

Iraci Ls Torres (IL)

Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.
Pharmacology Department, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Felipe Fregni (F)

Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.

Wolnei Caumo (W)

Post-Graduate Program in Medical Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.
Laboratory of Pain and Neuromodulation, HCPA, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.
Surgery Department, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.
Pain and Palliative Care Service, HCPA, Porto Alegre, Brazil, wcaumo@hcpa.edu.br.

Classifications MeSH